Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort
出版年份 2019 全文链接
标题
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-19
DOI
10.1038/s41598-019-49638-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
- (2018) Natalie C. Wu et al. BREAST CANCER RESEARCH AND TREATMENT
- Interlaboratory variability of Ki67 staining in breast cancer
- (2017) Cornelia M. Focke et al. EUROPEAN JOURNAL OF CANCER
- St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
- (2016) Cornelia M. Focke et al. BREAST CANCER RESEARCH AND TREATMENT
- Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
- (2016) Sara Bustreo et al. BREAST CANCER RESEARCH AND TREATMENT
- Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours
- (2016) Cornelia M Focke et al. HISTOPATHOLOGY
- Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma
- (2016) Koji Arihiro et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer
- (2016) Fangfang Zhong et al. PLoS One
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Strategies for developing Ki67 as a useful biomarker in breast cancer
- (2015) Carsten Denkert et al. BREAST
- Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
- (2015) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
- (2015) Matthias Christgen et al. HUMAN PATHOLOGY
- Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
- (2015) Akira I Hida et al. JOURNAL OF CLINICAL PATHOLOGY
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
- (2015) Rumiko Tashima et al. PLoS One
- Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
- (2015) Zsuzsanna Varga et al. PLoS One
- Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study
- (2014) F. Klauschen et al. CLINICAL CANCER RESEARCH
- Proliferationsbestimmung beim Mammakarzinom durch den immunhistochemischen Nachweis von Ki-67
- (2014) M. Christgen et al. PATHOLOGE
- Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays
- (2014) Gøril Knutsvik et al. PLoS One
- Assessment of the Ki67 labeling index: a Japanese validation ring study
- (2014) Naoki Niikura et al. Breast Cancer
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
- (2013) C. Denkert et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
- (2013) Yoshiki Mikami et al. CANCER SCIENCE
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Bestimmung der Proliferation: Stanze oder Resektat?
- (2012) E.C. Obermann et al. PATHOLOGE
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
- (2011) P. Karlsson et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2008) Giuseppe Viale et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now